The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Healthia (HLA) is set to purchase Natural Fit Footware and three physiotherapy clinics in North Queensland for around $3.3 million
  • Natural Fit Footware is a speciality footwear retailer which includes six stores and an e-commerce site
  • The footwear retailer is expected to bring in a revenue of around $6.1 million to Healthia
  • Additionally, Healthia will purchase three physiotherapy clinics in Northern Queensland
  • The company has also completed its recent purchase of one podiatry clinic in South Australia and the CQ Physio Group
  • On market close, Healthia remains in the grey and trading for $1.03 per share

Healthia (HLA) is set to purchase Natural Fit Footware and three physiotherapy clinics in North Queensland for around $3.3 million.

The company has entered into agreements to purchase Natural Fit Footwear, a speciality footwear retailer. Natural Fit Footwear includes six stores – five in New South Wales and one in Victoria – and an online website.

The footwear retailer will fit in with Healthia’s podiatry division, where the company currently owns and operates 10 retail footwear stores.

“In addition, Healthia will use the established e-commerce platform created by
Natural Fit Footwear to extend an online retail footwear offering to the patients of its 94 podiatry clinics,” the company told the market.

National Fit Footwear was created in 2017 and retails brands such as Ecco, Klouds, Frankie4, Revere, Vionic, Skechers, Saucony and Birkenstock.

The footwear stores and e-commerce platform is expected to bring in a revenue of around $6.1 million.

Additionally, Healthia will purchase three physiotherapy clinics in Northern Queensland, dubbed North Queensland Physiotherapy Centre. The Queensland stores are expected to bring in a revenue of nearly $2 million.

Settlement of physiotherapy clinics is expected to be completed before the end of the year.

Healthia has also completed its recent purchase of one podiatry clinic in South Australia and the CQ Physio Group.

On market close, Healthia remains in the grey and trading for $1.03 per share.

HLA by the numbers
More From The Market Online

Inoviq closes the gap on blood test results for ovarian cancer

INOVIQ has announced encouraging blood test identification results for ovarian cancer – cancer-positive tests saw a…

Paradigm Biopharma on track to US Phase III osteo program

Paradigm Biopharma has announced its completion of a submission to the US FDA to progress to…

Firebrick Pharma’s US launch of Nasal Spray is nothing to be sneezed at

Australian pharmaceutical developer, Firebrick Pharma (ASX:FRE) has launched its latest product, Nasodine Nasal Spray, in the…